| MSD Merck Sharp & Dohme AG - Prevymis 120 mg, Granulat | | 69867 | | 02 | | Prevymis 120 mg | | Granulat | | J05AX18 | | Letermovir | | 08.07.2025 | | |
| | Composition | | letermovirum 120 mg, cellulosum microcristallinum, polyvidonum K 29-32, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 9.9 mg, triacetinum, E 172 (flavum), E 172 (rubrum), ad granulatum, pro charta corresp. natrium 1.35 mg. | | Packungsbestandteile | | Granulate | | | | | | Active Agent | Dose |
|---|
| Letermovirum | 120 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Ad Granulatum | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 9.9 mg | | | Magnesii Stearas | | | | Polyvidonum K | 29-32 | | | Silica Colloidalis Anhydrica | | | | Titanium Dioxide | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 | | | A | | No |
|
|
